• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD have to make a difficult choice about whether to continue or stop taking ADHD medication during pregnancy and breast-feeding. There is a lack of information about how long-term exposure to these medications can affect the foetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Women who are pregnant and take adhd inattentive type medication medication should evaluate the benefits of using it against the possible dangers for the fetus. Physicians don't have the data to give clear advice, but can provide information on the risks and benefits to help pregnant women make informed decisions.

A study published in Molecular Psychiatry found that women who used ADHD medications during their early pregnancy did not have an increased risk of fetal cardiac malformations or major structural birth defects. The researchers used a large population-based case-control study to assess the risk of major structural birth defects in infants born to mothers who had taken stimulants in early pregnancy and those who had not. Clinical geneticists, pediatric cardiologists and other experts looked over the cases to confirm that the classification was accurate and to reduce any bias.

However, the study had its limitations. The researchers were not able to, in the first place to distinguish the effects caused by the medication from the disorder. This makes it difficult to determine whether the limited associations observed in the groups that were exposed are due to the use of medication or comorbidities that cause confusion. Researchers also did not study long-term outcomes for offspring.

The study did show that infants whose mothers took ADHD medication during pregnancy were at a greater risk of being admitted to the neonatal intensive care unit (NICU) than those who were born without any medication or cut back on their medications prior to or during pregnancy. This increase was due to central nervous system-related disorders, and the increased risk of admission did not appear to be influenced by the stimulant medications were used during pregnancy.

Women who took stimulant ADHD medication during pregnancy also had an increased risk of having a caesarean section or having a baby born with an low Apgar score (less than 7). These increases did appear to be independent of the type of medication taken during pregnancy.

The research suggests that the small risk associated with the use of ADHD medications during early pregnancy may be offset by the higher benefit for both mother and child of continuing treatment for the woman's disorder. Physicians should discuss the issue with their patients and, if possible, assist them in developing strategies for improving their coping skills that can lessen the negative impact of her condition on her daily life and relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and treated with medication, the question of whether to continue or discontinue treatment during pregnancy is a question that more and more doctors confront. The majority of these decisions are taken in the absence of solid and reliable evidence in either case, which means that doctors must weigh what they know, the experiences of other doctors, and what research says on the topic, along with their own judgments for each patient.

Particularly, the issue of potential risks for the baby can be tricky. The research that has been conducted on this topic is based on observation instead of controlled studies and the results are in conflict. Most studies restrict their analysis to live-births, which could underestimate the severity of teratogenic effects which can cause abortions or terminations of pregnancy. The study presented in the journal club addresses these issues by analyzing both data on live and deceased births.

The conclusion The conclusion: While some studies have found that there is a positive correlation between ADHD medications and the possibility of certain birth defects, others have found no such relationship and the majority of studies show a neutral or even slight negative effect. Therefore, a careful risk/benefit analysis must be done in each case.

For many women with ADHD and ADD, the decision to discontinue medication can be difficult, if not impossible. In fact, in a recent article in Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of loneliness, and family conflict for patients with ADHD. The loss of medication can affect the ability to safely drive and to perform work-related tasks which are essential aspects of normal life for people with ADHD.

She recommends that women who are unsure about whether to keep or discontinue medication due to their pregnancy consider educating family members, friends, and coworkers on the condition, its impact on daily functioning, and the benefits of keeping the current treatment regimen. It will also help a woman feel supported in her decision. It is important to remember that some medications are able to pass through the placenta, therefore, if a patient decides to stop her ADHD medication during pregnancy and breastfeeding, she must be aware that the effects of the drug can a general physician prescribe adhd medication be passed on to the baby.

Birth Defects and Risk of

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases, so do concerns about what impact the drugs could have on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this subject. With two massive data sets, researchers were able to examine more than 4.3 million pregnancies to determine whether stimulant medications increased the risk of birth defects. While the overall risk is low, the researchers found that exposure in the first trimester to ADHD medicines was associated with an increased risk of specific heart defects, like ventriculo-septal defects (VSD).

The researchers of the study did not find any association between the use of early medications and congenital anomalies such as facial deformities or club feet. The results are in line with previous studies showing an increase, but not significant, in the risk of developing cardiac malformations in women who started taking ADHD medications prior to the time of the birth of their child. This risk increased during the latter part of pregnancy, as many women decide to stop taking their ADHD medications.

Women who used ADHD medications in the first trimester of their pregnancies were also more likely to have caesarean section, low Apgar score after delivery and a baby who needed breathing assistance during birth. However the authors of the study were not able to eliminate bias due to selection by limiting the study to women who did not have other medical issues that could be a contributing factor to these findings.

The researchers hope their research will aid in the clinical decisions of physicians who treat pregnant women. They advise that while discussing the benefits and risks is important but the decision to stop or keep treatment must be based on each woman's needs and the severity of her ADHD symptoms.

The authors warn that, although stopping the medication is an option to consider, it is not advised due to the high prevalence of depression and other mental disorders among women who are pregnant or recently gave birth. Additionally, the research suggests that women who decide to stop their medications are more likely to experience a difficult time adjusting to life without them after the baby's arrival.

Nursing

The responsibilities of a new mom can be overwhelming. Women who suffer from ADHD who have to manage their symptoms while attending physician appointments, getting ready for the arrival of their child and adjusting to new household routines are often faced with a number of difficulties. As such, many women elect to continue taking their ADHD medication throughout the pregnancy.

The majority of stimulant medications are absorbed through breast milk in very small quantities, so the risk for nursing infant is very low. The rate of exposure to medication can vary depending upon the dosage and frequency of administration as well as the time of day. Additionally, different drugs enter the infant's system via the gastrointestinal tract, or through breast milk. The impact of these medications on the health of a newborn isn't fully known.

Some doctors may stop taking stimulant medications during a woman's pregnancy due to the lack of research. It's a difficult choice for the woman, who must weigh the advantages of taking her medication as well as the potential risks to the embryo. As long as there is no more information, GPs should ask all pregnant patients about their history of ADHD and if they plan or are taking to take medication during the perinatal time.

Many studies have shown that women can continue to take their ADHD medication without risk during pregnancy and breast-feeding. In response, an increasing number of patients are choosing to do so. They have concluded, in consultation with their physicians, that the benefits of retaining their current medication outweigh possible risks.

It is crucial for women suffering from ADHD who prescribes adhd medication are considering breastfeeding to seek a specialist psychiatrist's advice prior to becoming pregnant. They should discuss their medication with their doctor and discuss the advantages and disadvantages of continuing treatment, including non stimulant adhd medication list-pharmacological management strategies. Psychoeducation is also required to help women with ADHD be aware of their symptoms and underlying disorder Learn about the available treatment options and reinforce existing strategies for coping. This should be a multidisciplinary approach together with obstetricians, GPs and psychiatrists. The pregnancy counselling should consist of the discussion of a plan for management for both the mother and child, and monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.